SCHEMBL21323347

SCHEMBL21323347

O=C(/C=C/c1ccc(F)cc1)N1CCC2CN(C(=O)c3ccc4[nH]nnc4c3)CC2CC1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ GPR183 P32249 12/20 0.48
▸ ALDH1A1 P00352 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ KCNH2 Q12809 2/20 0.41
▸ KDM1A O60341 2/20 0.40
▸ HDAC6 Q9UBN7 2/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ENPP2 Q13822 1/20 0.40
▸ ATXN2 Q99700 1/20 0.40
▸ MAPK1 P28482 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16962642 1.00 GPR183 (0.48) GPR183ALDH1A1LMNATP53KCNH2
SCHEMBL16962640 1.00 GPR183 (0.48) GPR183ALDH1A1LMNATP53KCNH2
SCHEMBL21323348 1.00 GPR183 (0.48) GPR183ALDH1A1LMNATP53KCNH2
SCHEMBL16962980 0.91 GPR183 (0.48) GPR183ALDH1A1LMNATP53KCNH2
SCHEMBL16963788 0.91 GPR183 (0.48) GPR183KCNH2KMT2AENPP2ATXN2
SCHEMBL21323086 0.91 GPR183 (0.48) GPR183ALDH1A1LMNATP53KCNH2
SCHEMBL21322984 0.91 GPR183 (0.48) GPR183KCNH2KMT2AENPP2ATXN2
SCHEMBL16962977 0.91 GPR183 (0.48) GPR183ALDH1A1LMNATP53KCNH2
SCHEMBL21322986 0.91 GPR183 (0.48) GPR183KCNH2KMT2AENPP2ATXN2
SCHEMBL16963790 0.91 GPR183 (0.48) GPR183KCNH2KMT2AENPP2ATXN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback